These newer therapies, including Semaglutide , belong to a class of drugs called GLP-1 agents. Originally developed for treating high blood sugar, they operate by assisting the organism to secrete adequate the hormone insulin and curbing high glucose levels. Beyond diabetes, their potential to promote weight management has resulted to significant i